// February 08, 2019
Our Legacy of Championing Access to Medicines
Access to medicines is a complicated topic.
Access to medicines is a complicated topic.
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone
Therapeutic peptides occupy an interesting space along the molecular continuum between traditiona
Recently, I was privileged to serve as a private advisor member of the U.S.